| [1] |
Leon MB, Smith CR, Mack M. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363(17):1597-607.
|
| [2] |
Davidson LJ, Davidson CJ. Transcatheter treatment of valvular heart disease: a review. JAMA. 2021; 325(24): 2480-94.
doi: 10.1001/jama.2021.2133
pmid: 34156404
|
| [3] |
van der Werf HW, Douglas YL, van den Heuvel AFM. TAVI in heart failure, how much risk is acceptable? Eur J Heart Fail. 2012; 14(10): 1087-9.
pmid: 22956575
|
| [4] |
Lee G, Chikwe J, Milojevic M, Wijeysundera HC, Biondi-Zoccai G, Flather M, et al. ESC/EACTS vs. ACC/AHA guidelines for the management of severe aortic stenosis. Eur Heart J. 2023; 44(10): 796-812.
doi: 10.1093/eurheartj/ehac803
pmid: 36632841
|
| [5] |
Chiang M, Gonzalez PE, O’Neill BP, Lee J, Frisoli T, Wang DD, et al. Left atrial venoarterial extracorporeal membrane oxygenation for acute aortic regurgitation and cardiogenic shock. JACC Case Rep. 2022; 4(5):276-9.
|
| [6] |
Raffa GM, Kowalewski M, Meani P, Follis F, Martucci G, Arcadipane A, et al. In-hospital outcomes after emergency or prophylactic veno-arterial extracorporeal membrane oxygenation during transcatheter aortic valve implantation: a comprehensive review of the literature. Perfusion. 2019; 34(5): 354-63.
doi: 10.1177/0267659118816555
pmid: 30632894
|
| [7] |
Seco M, Forrest P, Jackson SA, Martinez G, Andvik S, Bannon PG, et al. Extracorporeal membrane oxygenation for very high-risk transcatheter aortic valve implantation. Heart Lung Circ. 2014; 23(10): 957-62.
doi: 10.1016/j.hlc.2014.05.006
pmid: 24954708
|
| [8] |
Fu B, Zhang SP, Dai SL, Guo ZG, Jiang N, Han JG, et al. Left ventricular ejection fraction is associated with intraoperative circulatory collapse during transcatheter aortic valve implantation. Ann Transl Med. 2021; 9(16): 1336.
|
| [9] |
Ajmi I, Mahnkopf C, Brachmann J, Sinani M, Oudeh M, Schnupp S. Rotablation of heavily calcified left main stenosis and aortic valve valvuloplasty under ECMO cardiopulmonary support. JACC Case Rep. 2020; 2(15): 2448-54.
|
| [10] |
Ahmad S, Ahsan MJ, Ikram S, Lateef N, Khan BA, Tabassum S, et al. Impella versus extracorporeal membranous oxygenation (ECMO) for cardiogenic shock: a systematic review and meta-analysis. Curr Probl Cardiol. 2023; 48(1): 101427.
|
| [11] |
Salter BS, Gross CR, Weiner MM, Dukkipati SR, Serrao GW, Moss N, et al. Temporary mechanical circulatory support devices: practical considerations for all stakeholders. Nat Rev Cardiol. 2023; 20(4): 263-77.
|
| [12] |
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
|
| [13] |
Cumming G. Inference by eye: reading the overlap of independent confidence intervals. Stat Med. 2009; 28(2): 205-20.
doi: 10.1002/sim.3471
pmid: 18991332
|
| [14] |
Fiorina C, Coletti G, D’Aloia A, Chizzola G, Curello S, Maffeo D, et al. TAVI in low-flow low-gradient aortic stenosis: Early experience. EuroIntervention. 2011;7:M225.
|
| [15] |
Husser O, Holzamer A, Philipp A, Nunez J, Bodi V, Müller T, et al. Emergency and prophylactic use of miniaturized veno-arterial extracorporeal membrane oxygenation in transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2013; 82(4):E542-51.
|
| [16] |
Unbehaun A, Pasic M, Buz S, Dreysse S, Kukucka M, Hetzer R, et al. Transapical aortic valve implantation in patients with severely depressed left ventricular function. J Thorac Cardiovasc Surg. 2012; 143(6): 1356-63.
doi: 10.1016/j.jtcvs.2011.07.008
pmid: 21840548
|
| [17] |
Drews T, Pasic M, Buz S, D’Ancona G, Mladenow A, Hetzer R, et al. Elective femoro-femoral cardiopulmonary bypass during transcatheter aortic valve implantation: a useful tool. J Thorac Cardiovasc Surg. 2013; 145(3): 757-63.
doi: 10.1016/j.jtcvs.2012.02.012
pmid: 22405673
|
| [18] |
Ichibori Y, Mizote I, Maeda K, Ohtani T, Torikai K, Kuratani T, et al. Safety and efficacy of elective cardiopulmonary bypass support during TAVI in patients at high risk for hemodynamic instability. J Card Fail. 2014; 20(10): S176.
|
| [19] |
Seco M, Martinez G, Bannon PG, Cartwright BL, Adams M, Ng M, et al. Transapical aortic valve implantation - an Australian experience. Heart Lung Circ. 2014; 23(5): 462-8.
doi: 10.1016/j.hlc.2013.10.095
pmid: 24315653
|
| [20] |
Scherner M, Madershahian N, Ney S, Kuhr K, Rosenkranz S, Rudolph TK, et al. Focus on the surgical approach to transcatheter aortic valve implantation: complications, outcome, and preoperative risk adjustment. J Thorac Cardiovasc Surg. 2015; 150(4): 841-9.
doi: 10.1016/j.jtcvs.2015.06.030
pmid: 26424369
|
| [21] |
Shreenivas SS, Lilly SM, Szeto WY, Desai N, Anwaruddin S, Bavaria JE, et al. Cardiopulmonary bypass and intra-aortic balloon pump use is associated with higher short and long term mortality after transcatheter aortic valve replacement: a PARTNER trial substudy. Catheter Cardiovasc Interv. 2015; 86(2): 316-22.
|
| [22] |
McCarthy FH, Spragan DD, Savino D, Dibble T, Hoedt AC, McDermott KM, et al. Outcomes, readmissions, and costs in transfemoral and alterative access transcatheter aortic valve replacement in the US Medicare population. J Thorac Cardiovasc Surg. 2017; 154(4): 1224-32.e1.
|
| [23] |
Uehara K, Minakata K, Saito N, Imai M, Daijo H, Nakatsu T, et al. Use of extracorporeal membrane oxygenation in complicated transcatheter aortic valve replacement. Gen Thorac Cardiovasc Surg. 2017; 65(6): 329-36.
|
| [24] |
Goel K, Nkomo VT, Slusser JP, Lennon R, Brown RD, Greason KL, et al. Relationship between procedural characteristics and cerebrovascular events after transcatheter aortic valve replacement. Open Heart. 2018; 5(2): e000816.
|
| [25] |
Higuchi R, Tobaru T, Hagiya K, Saji MK, Takamisawa I, Shimizu J, et al. Outcomes of patients requiring extracorporeal membrane oxygenation in transcatheter aortic valve implantation: a clinical case series. Heart Vessels. 2018; 33(11): 1343-9.
doi: 10.1007/s00380-018-1183-8
pmid: 29721672
|
| [26] |
Alkhalil A, Hajjar R, Ibrahim H, Ruiz CE. Mechanical circulatory support in transcatheter aortic valve implantation in the United States (from the national inpatient sample). Am J Cardiol. 2019; 124(10): 1615-20.
doi: S0002-9149(19)30953-1
pmid: 31522773
|
| [27] |
Trenkwalder T, Pellegrini C, Holzamer A, Rheude T, Riester J, Reinhard W, et al. Prophylactic ECMO during TAVI in patients with depressed left ventricular ejection fraction. Clin Res Cardiol. 2019; 108(4): 366-74.
doi: 10.1007/s00392-018-1364-6
pmid: 30155732
|
| [28] |
Govender K, Jani VP, Cabrales P. The disconnect between extracorporeal circulation and the microcirculation: a review. ASAIO J. 2022; 68(7): 881-9.
doi: 10.1097/MAT.0000000000001618
pmid: 35067580
|
| [29] |
Smith AH, Hardison DC, Bridges BC, Pietsch JB. Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation. Perfusion. 2013; 28(1): 54-60.
doi: 10.1177/0267659112457969
pmid: 22892295
|
)
